Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wis.
Department of Medicine, University of Wisconsin, Madison, Wis.
J Allergy Clin Immunol. 2020 Jun;145(6):1699-1701. doi: 10.1016/j.jaci.2020.01.022. Epub 2020 Jan 28.
After EoE treatment, association of platelets with blood eosinophils, as reported by CD41, predicted esophageal eosinophil count. Percentage CD41+ circulating eosinophils is a potential non-invasive biomarker for EoE disease activity.
在 EoE 治疗后,通过 CD41 报告的血小板与血液嗜酸性粒细胞的关联预测了食管嗜酸性粒细胞计数。循环嗜酸性粒细胞中 CD41+的百分比是 EoE 疾病活动的潜在非侵入性生物标志物。